Developing better ways of diagnosing disease at intersection of disciplines
Ph.D. candidate creating new kind of microfluidic device to test for respiratory diseases
Existing drug mastinib is shown to inhibit SARS-CoV-2 virus
Mastinib, not yet approved for use in humans, shows good results in early UChicago studies
